Company NFL Biosciences

Stocks

ALNFL

FR0014003XT0

Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 05:29:53 2026-07-06 EDT			5-day change	1st Jan Change
0.8890 ^EUR	+3.73%		+2.07%	-24.53%

06-30	NFL Biosciences Successfully Manufactures GMP Clinical Batch Of NFL-102 And Validates Industrial Production Chain	CI
06-30	NFL Biosciences validates industrial-scale production of NFL-102 for smoking cessation

Business description: NFL Biosciences

NFL Biosciences specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents.

At the end of 2025, the company has two products in clinical development (NFL-101 and NFL-102) and two products in preclinical development (NFL-201 for the treatment of cannabis addiction and NFL-301 for alcohol addiction).

Number of employees: 4

Sales by Activity: NFL Biosciences

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Biotechnology (Startups)	39	22	200K	46	188

See all business segments

Geographical breakdown of sales: NFL Biosciences

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
France	39	22	200K	46	188

See all geographic segments

Executive Committee: NFL Biosciences

Manager	Title	Age	Since
Bruno Lafont CEO	Chief Executive Officer	-	2024-10-16
Guillaume Audema DFI	Director of Finance/CFO	-	-
Violaine Desort Henin CTO	Chief Tech/Sci/R&D Officer	-	-
Ignacio Faus CEO	Chief Executive Officer	-	2021-05-18
Lara Babich PRN	Corporate Officer/Principal	-	2023-12-31

See NFL BIOSCIENCES governance

Composition of the Board of Directors: NFL Biosciences

Director	Title	Age	Since
Ignacio Faus CHM	Chairman	-	2023-02-26
Bruno Lafont CHM	Chairman	-	2024-10-16
Francis Ahner BRD	Director/Board Member	-	2021-05-18
Yannick Plétan BRD	Director/Board Member	-	2021-05-18
Dominique Côté BRD	Director/Board Member	-	2023-05-31

Composition of the Board of Directors

Shareholders: NFL Biosciences

Name	Stocks	%	Valuation
Friedland Gestion SAS 0.1609 %	20,395	0.1609 %	24 419 €

List of NFL BIOSCIENCES shareholders

Company details: NFL Biosciences

NFL Biosciences SAS

199 rue Hélène Boucher

34170, Castelnau-le-Lez

+33 4 11 93 76 67

http://www.nflbiosciences.com

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NFL BIOSCIENCES	+3.73%	+2.07%	-24.02%	-64.72%	12.42M
ARGENX SE	-0.07%	+5.70%	+78.19%	+135.99%	59.1B
WUXI APPTEC CO., LTD.	+2.32%	+5.03%	+75.26%	+92.31%	55.19B
BIONTECH SE	+3.86%	+6.93%	-11.32%	-10.57%	24.67B
INSMED INCORPORATED	+4.30%	+7.95%	+14.11%	+440.44%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	+0.64%	+7.14%	+50.90%	-1.05%	19.69B
GENMAB A/S	-0.62%	+8.03%	+41.93%	-28.49%	17.56B
PHARMAESSENTIA CORPORATION	0.00%	+20.78%	+186.15%	+347.42%	16.22B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+4.91%	+20.18%	+48.55%	-	14.84B
EXELIXIS, INC.	+3.50%	+1.97%	+21.02%	+193.33%	14.04B
Average	+2.26%	+7.91%	+48.08%	+122.74%	24.55B
Weighted average by Cap.	+1.82%	+6.47%	+59.51%	+135.92%